Peer Review History
| Original SubmissionApril 29, 2024 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-24-16447The protein interactome of Escherichia coli carbohydrate metabolism.PLOS ONE Dear Dr. Uetz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Manuscript has been reviewed by 2 subject experts. You may go through their comments. Both have shown interest in the work and appreciated in the importance of hypothesis. They have given their comments and suggestions. I could gather that the conclusion drawn from provided data is not convincing and therefore, it needs a complete rewriting. Reviewer 1 did not find much of new information and the importance of study on regulation of enzyme activity by protein -protein interaction has come nicely. This point should be brought out in revision. Please submit your revised manuscript by Aug 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary: This study aimed to investigate how carbohydrate metabolism (CHM) in E. coli is regulated by their interaction properties with other proteins and their quantities. By collecting published protein abundance data from reference [15] and PPI data from the IntAct database from references [31-33], they built a list of 378 PEIs (protein enzyme interactions) for carbohydrate metabolism enzymes. Then, each component of PEIs was assigned with their normalized abundance values (protein copies/cell) under 22 different growth conditions. By interpretation only, they showed examples of PEI changes in response to growth conditions, possibly due to tug-of-war bindings through secondary interactors or the direct completion for the shared binding sites. Finally, the consequent pair-wise PEI stoichiometry (the abundance ratio between enzymes and their interactors) was used to “predict/hypothesize” the potential regulators of E. coli carbohydrate metabolism. Generally, this is a pure in silico study using published data. The purpose of this study is straightforward. The PEIs summarized are intuitive. However, I feel this is an incomplete and immature research and the manuscript is not well prepared. Moreover, I do not think this study provides sufficient new knowledge. Finally, I cannot agree that this study directly addresses the primary question of “how carbohydrate metabolism (CHM) in E. coli is regulated by their interaction properties with other proteins and their quantities” which they claimed in the Abstract and Conclusion. Major comments: 1. “PEIs” is a relatively new conceptual PPI category. It focuses on enzymes and their interactors. Although not strongly mentioned in the manuscript, it seems there is a hypothesis that the interactors are likely to be the regulators of the enzyme, and quantitatively or qualitatively changing the interactors might be a potential mechanism to regulate the enzyme. However, I feel disappointed to find out that this study only generates a list of PEIs, which makes no clear difference from its sources IntAct database. Moreover, in the whole manuscript, I could feel the authors tried very hard to search for many works of literature to support or imply the potential of their findings related to PEIs. However, there is still nothing new from the PEIs in this study even if some literature had previously identified the same enzyme-protein interaction as their PEIs list. In the end, it turned out that the interpretation of the results/discussion looked like just a literature review. 2. From the M/M to Results section, it looks like a direct copy and paste from a student thesis. The Results are fragmented and lacking clear logical connections. At least, each experiment or analysis should be composed of (1) scientific motivations/questions, (2) methodologies to investigate the issues (3) results, and (4) interpretations. Moreover, the figure legends are dispersed throughout the manuscript and it is difficult to find them. It is disrespectful to reviewers who have to wade through it. To me, the Discussion is relatively better in the scientific context. I would suggest to rewrite a mixed Results/Discussion section. 3. It is confusing how to define and classify the “primary” and “secondary” interactors of the same enzyme/protein. Is it based on ratio or absolute abundance? 4. P11, “Enzymes and interactors compete with other proteins to bind to each other”. Honestly, I am not convinced by simple discussions to claim that interactors compete with each other when only “predicted” overlapped binding sites are shown. 5. Abstract, P12, Conclusions. “E. coli protein-enzyme interactions may regulate carbohydrate metabolism”, I do not see any solid and direct evidence to support this conclusion solely according to the data generated in this study. The only way I can think of to improve this study is to perform some wet experiments to verify some previously unpublished and uninvestigated PEIs and then to prove that the interactor plays roles in the regulation of the paired enzyme. Minor comments: 1. Table 1: change “KEGG_Num” to “KEGG Identifier”. 2. Intuitively, “non-metabolic enzyme” sounds make no sense to me. I assume all enzymes work for metabolisms of the organism. Please clarify this definition, and provide some examples showing an enzyme with non-metabolic functions. 3. Please provide more detailed information in M/M for the “Conservation of PEIs” analysis. It is also good to know the classification of bacterial OG species used. 4. It would be also good to add one more column in Table S1 after “Enzyme” and “Interactor” to specify their functions, e.g., dehydrogenase, converting A from B, a regulator of enzyme X, etc. 5. P5, “Number of PEIs scale with pathway size.” It is not surprising at all. PPI is universal. A bigger pathway composed of more enzymes of course gets more interactors. I will not feel this is an informative analysis unless “PEI density (numbers of interactors per enzyme)” is used for comparison and then some specific pathways are found to have unexpected higher or lower PEI density. 6. P12, L396, the M/M for using ChimeraX and comparing overlapped binding sites is missing. 7. Are the two interacting proteins' protein structures based on AlphaFold completely? In other words, are their interaction based on a predicted model or real protein crystal structures? 8. P9, except for the galactose examples, how do you explain the other “inverse stoichiometry” cases? 9. Fig S1-S5, what do “_E” ,“_I”, and “G_” stand for in the growth conditions X-axis? 10. Fig S1-S5 needs to be re-prepared. Some gene name tags close to the Y-axis and right side border are truncated. 11. Fig 10, move the statement “Schmidt et al [15] PEIs count = 179 in the figure to the figure legend or direct remove it. Reviewer #2: The authors studied over 300 protein-enzyme interactions (PEIs) for carbohydrate metabolism (CHM) enzymes in E. coli and found extensively interactions with other metabolic enzymes as well as non-metabolic proteins. The authors showed that many PEIs vary with metabolic conditions, showing significant regulatory dynamics. The authors also investigated secondary interactors that could compete with PEIs and offered some likely mechanisms of regulatory functions of the enzyme interaction partners. Major concerns: 1. The authors should justify the use of the IntAct database to retrieve PEIs as there are many PPI databases. 2. The authors studies possible effects of secondary interactors under the assumption of competing roles. Secondary interactors could also facilitate the interaction of a PEI if they form stable multi-subunit complexes. This possibility should be mentioned. 3. Details of how the contacts are calculated in Table 4 and Figure 6 should be given in materials and methods. Are they based on experimental structures or compute-modeled structures? If experimental structures were used, the PDB codes of the structures shown in Figure 6 should be given. 4. While the secondary interaction and a PEI may share a certain fraction of contacting residues, they may not interfere with each other. Superposition of secondary interaction complex and the PEI complex to detect spatial clashes would be more suitable to infer competing roles of a secondary interactor. 5. The pLDDT score is residue based. Are the pLDDT scores in Figures 7 and 8 the average of all pLDDTs? pLDDT cannot be used to quantify the confidence of the complex. The authors can use AlphaFold3 to model the complex and use the PTM and iPTM scores as confidence measures of the overall complex and the interface respectively. Minor points: Page 2, line 11, Escherichia coli: change to italic. Line 22, Hpr (italic): change to regular font HPr. Page 3, line 56. It is not clear what “non-spoke expanded interactions” means. Page 8, line 257 mentioned “PEIs in red in Table 5”. However, there is no red marking in Table 5. To make the supplementary tables more informative, add gene names in Tables S1, S2 and S3 and add UniProt accessions in Table S4. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-16447R1The protein interactome of Escherichia coli carbohydrate metabolism.PLOS ONE Dear Dr. Uetz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process and by editor as appended below. Figures and legends in revised manuscript seems to have got inadvertently duplicated. Authors did not check the final version before submission. They are suggested to revise the revised manuscript, scrutinize carefully and then submit as a revision. Please submit your revised manuscript by Dec 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The protein interactome of Escherichia coli carbohydrate metabolism. PONE-D-24-16447R2 Dear Dr. Uetz, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hari S. Misra, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-16447R2 PLOS ONE Dear Dr. Uetz, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Hari S. Misra Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .